We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current NXTC market cap is 21.82M. The company's latest EPS is USD -2.2396 and P/E is -0.34.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -15.62M | -15.79M | -16.52M | -16.5M | -12.5M |
| Net Income | -14.3M | -14.47M | -17.11M | -15.4M | -11.54M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 6.35M | 22.38M | 0 | 0 | 0 |
| Operating Income | -37.48M | -41.23M | -70.77M | -75.91M | -67.64M |
| Net Income | -33.74M | -36.6M | -69.39M | -74.73M | -62.72M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 139.94M | 128.04M | 115.16M | 102.59M | 90.35M |
| Total Liabilities | 13.49M | 13.62M | 16.11M | 17.15M | 14.75M |
| Total Equity | 126.45M | 114.42M | 99.05M | 85.44M | 75.59M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 356.17M | 306.64M | 242.39M | 184.16M | 128.04M |
| Total Liabilities | 34.68M | 12.92M | 9M | 16.63M | 13.62M |
| Total Equity | 321.48M | 293.72M | 233.39M | 167.53M | 114.42M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -42.3M | -52.97M | -12.61M | -22.38M | -33.84M |
| Investing | 35.11M | 39.27M | 17.88M | 30.04M | 48.35M |
| Financing | 83k | 154k | 1,000 | 107k | 108k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -35.62M | -44.95M | -57.24M | -53.89M | -52.97M |
| Investing | -303.92M | 43.52M | 36.6M | 67.98M | 39.27M |
| Financing | 243.04M | -1.42M | -3.27M | 200k | 154k |
| Market Cap | 21.82M |
| Price to Earnings Ratio | -0.34 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.63 |
| Price to Book Ratio | 0.19 |
| Dividend Yield | - |
| Shares Outstanding | 28.01M |
| Average Volume (1 week) | 31.37k |
| Average Volume (1 Month) | 52.29k |
| 52 Week Change | -59.64% |
| 52 Week High | 2.57 |
| 52 Week Low | 0.6603 |
| Spread (Intraday) | 0.18 (21.18%) |
| Company Name | NextCure Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.nextcure.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
